37.5 USD
+0.3 (+0.81%)
Overall KEQU gets a fundamental rating of 5 out of 10. We evaluated KEQU against 185 industry peers in the Health Care Equipment & Supplies industry. KEQU has only an average score on both its financial health and profitability. KEQU is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- KEQU had positive earnings in the past year.
- KEQU had a positive operating cash flow in the past year.
- In multiple years KEQU reported negative net income over the last 5 years.
- The reported operating cash flow has been mixed in the past 5 years: KEQU reported negative operating cash flow in multiple years.
1.2 Ratios
- KEQU's Return On Assets of 6.21% is amongst the best of the industry. KEQU outperforms 84.86% of its industry peers.
- Looking at the Return On Equity, with a value of 16.81%, KEQU belongs to the top of the industry, outperforming 92.43% of the companies in the same industry.
- KEQU has a better Return On Invested Capital (10.67%) than 90.81% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for KEQU is in line with the industry average of 8.84%.
- The 3 year average ROIC (9.90%) for KEQU is below the current ROIC(10.67%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.21% | ||
| ROE | 16.81% | ||
| ROIC | 10.67% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
1.3 Margins
- With a decent Profit Margin value of 4.11%, KEQU is doing good in the industry, outperforming 75.68% of the companies in the same industry.
- KEQU's Operating Margin of 6.89% is fine compared to the rest of the industry. KEQU outperforms 72.43% of its industry peers.
- Looking at the Gross Margin, with a value of 29.09%, KEQU is doing worse than 75.68% of the companies in the same industry.
- In the last couple of years the Gross Margin of KEQU has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.89% | ||
| PM (TTM) | 4.11% | ||
| GM | 29.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KEQU is still creating some value.
- KEQU has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for KEQU has been increased compared to 5 years ago.
- Compared to 1 year ago, KEQU has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.30 indicates that KEQU is not in any danger for bankruptcy at the moment.
- The Altman-Z score of KEQU (3.30) is better than 70.27% of its industry peers.
- The Debt to FCF ratio of KEQU is 12.32, which is on the high side as it means it would take KEQU, 12.32 years of fcf income to pay off all of its debts.
- With a decent Debt to FCF ratio value of 12.32, KEQU is doing good in the industry, outperforming 72.43% of the companies in the same industry.
- A Debt/Equity ratio of 0.85 indicates that KEQU is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.85, KEQU is doing worse than 73.51% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 12.32 | ||
| Altman-Z | 3.3 |
ROIC/WACC1.07
WACC9.94%
2.3 Liquidity
- KEQU has a Current Ratio of 2.48. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
- KEQU's Current ratio of 2.48 is in line compared to the rest of the industry. KEQU outperforms 52.97% of its industry peers.
- A Quick Ratio of 1.71 indicates that KEQU should not have too much problems paying its short term obligations.
- KEQU has a Quick ratio (1.71) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.48 | ||
| Quick Ratio | 1.71 |
3. Growth
3.1 Past
- The earnings per share for KEQU have decreased strongly by -37.55% in the last year.
- The Revenue has grown by 43.02% in the past year. This is a very strong growth!
- The Revenue has been growing by 10.27% on average over the past years. This is quite good.
EPS 1Y (TTM)-37.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.15%
Revenue 1Y (TTM)43.02%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.76%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 7.43, which indicates a rather cheap valuation of KEQU.
- 96.76% of the companies in the same industry are more expensive than KEQU, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 27.33, KEQU is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.43 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 97.30% of the companies listed in the same industry.
- 90.27% of the companies in the same industry are more expensive than KEQU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.02 | ||
| EV/EBITDA | 6.05 |
4.3 Compensation for Growth
- The decent profitability rating of KEQU may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for KEQU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:KEQU (1/14/2026, 8:00:03 PM)
37.5
+0.3 (+0.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-10 2025-12-10/amc
Earnings (Next)03-10 2026-03-10
Inst Owners41.13%
Inst Owner Change0%
Ins Owners15.89%
Ins Owner Change-4.36%
Market Cap107.63M
Revenue(TTM)285.51M
Net Income(TTM)11.74M
Analysts82.86
Price TargetN/A
Short Float %1.66%
Short Ratio3.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.43 | ||
| Fwd PE | N/A | ||
| P/S | 0.38 | ||
| P/FCF | 21.02 | ||
| P/OCF | 12.42 | ||
| P/B | 1.54 | ||
| P/tB | 2.67 | ||
| EV/EBITDA | 6.05 |
EPS(TTM)5.05
EY13.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.78
FCFY4.76%
OCF(TTM)3.02
OCFY8.05%
SpS99.48
BVpS24.34
TBVpS14.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number52.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.21% | ||
| ROE | 16.81% | ||
| ROCE | 13.73% | ||
| ROIC | 10.67% | ||
| ROICexc | 11.69% | ||
| ROICexgc | 15.07% | ||
| OM | 6.89% | ||
| PM (TTM) | 4.11% | ||
| GM | 29.09% | ||
| FCFM | 1.79% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 12.32 | ||
| Debt/EBITDA | 2.29 | ||
| Cap/Depr | 56.58% | ||
| Cap/Sales | 1.24% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 33.42% | ||
| Profit Quality | 43.61% | ||
| Current Ratio | 2.48 | ||
| Quick Ratio | 1.71 | ||
| Altman-Z | 3.3 |
F-Score4
WACC9.94%
ROIC/WACC1.07
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.02%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1290.93%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y51.55%
OCF growth 3YN/A
OCF growth 5Y28.86%
KEWAUNEE SCIENTIFIC CP / KEQU FAQ
What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?
ChartMill assigns a fundamental rating of 5 / 10 to KEQU.
What is the valuation status of KEWAUNEE SCIENTIFIC CP (KEQU) stock?
ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.
How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?
KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.
How financially healthy is KEWAUNEE SCIENTIFIC CP?
The financial health rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 5 / 10.
Is the dividend of KEWAUNEE SCIENTIFIC CP sustainable?
The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.